Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00581308 · ClinicalTrials.gov registry record · NA
Long-term Safety Study of the GORE® HELEX® Septal Occluder
A NA study, sponsored by W.L.Gore & Associates.
- Completed
- Registry status
- NA
- Development phase
- 215
- Enrollment target
NCT00581308 is a NA study that has completed, run by W.L.Gore & Associates. The registered enrollment target is 215 participants.
The verdict
NCT00581308, a NA study, has completed, sponsored by W.L.Gore & Associates.
- COMPLETED
- Registry status
- NA
- Development phase
- 215 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the long-term safety and efficacy of the GORE® HELEX® Septal Occluder in the treatment of ostium secundum atrial septal defects (ASDs).
Interventions
- DEVICE GORE® HELEX® Septal Occluder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 215 participants |
| Start Date | 2006-08 |
| Est. Completion | 2014-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00581308
The ClinicalTrials.gov registry entry for NCT00581308 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 215 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is W.L.Gore & Associates, which has 53 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GORE® HELEX® Septal Occluder is the first listed.
NCT00581308 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00581308 about?
NCT00581308 is a clinical study titled "Long-term Safety Study of the GORE® HELEX® Septal Occluder". The purpose of this study is to evaluate the long-term safety and efficacy of the GORE® HELEX® Septal Occluder in the treatment of ostium secundum atrial septal defects (ASDs).
What is the current status of trial NCT00581308?
This trial is currently completed. It is a NA study. The enrollment target is 215 participants. The study started on 2006-08. Estimated completion is 2014-10.
What interventions are being tested in trial NCT00581308?
The interventions under investigation include: GORE® HELEX® Septal Occluder (DEVICE).
Who is sponsoring clinical trial NCT00581308?
This trial is sponsored by W.L.Gore & Associates, which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.